Neurosign 100, Product Number 9883-01. Intraoperative Nerve Monitor - Product Usage: indicated fo...

FDA Device Recall #Z-0869-2021 — Class II — December 8, 2020

Recall Summary

Recall Number Z-0869-2021
Classification Class II — Moderate risk
Date Initiated December 8, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm The Magstim Company Limited
Location Whitland, N/A
Product Type Devices
Quantity 7 units

Product Description

Neurosign 100, Product Number 9883-01. Intraoperative Nerve Monitor - Product Usage: indicated for use in stimulating and monitoring cranial motor nerves, especially the facial nerve (VII), during ENT surgical procedures.

Reason for Recall

A small number of Neurosign 100 Intraoperative Nerve Monitors may have been dispatched without being configured appropriately for the supply mains within the target Country. The specific deficiency includes: 1. Onboard voltage selector set to 240V (European Standard), versus 120V requirement for the United States and Canada. 2. Fuses installed in the Power Entry Module (PEM) 2xT315mAL (240V Standard), versus the 2xT630mAL requirement for a 120V mains supply.

Distribution Pattern

MN, NC, and NY

Lot / Code Information

Serial Numbers: 2507, 2511, 2514, 2515, 2522, 2527, 2533, 2534, 2537

Other Recalls from The Magstim Company Limited

Recall # Classification Product Date
Z-2884-2020 Class II Neurosign V4 Intraoperative Nerve monitor famil... Jun 23, 2020
Z-1965-2020 Class II Horizon PSU Stim Interconnecting Cable - Produc... Mar 23, 2020
Z-1966-2020 Class II Rapid2 PSU Stim Interconnecting Cable - Produ... Mar 23, 2020
Z-0836-2019 Class II HORIZON Ez Arm (Part of the HORIZON TMS Thera... Oct 25, 2018
Z-1352-2018 Class II Magstim Rapid Therapy System consisting of: Rap... Sep 28, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.